gentamicin has been researched along with Obesity, Morbid in 2 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on the study, we propose specific mg/kg dose reductions with decreasing CKD-EPI values for the obese population, and extension of the dosing interval beyond 24 h when CKD-EPI drops below 50 mL/min/1." | 5.56 | Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function. ( Becker, ML; Brüggemann, RJM; Knibbe, CAJ; Smit, C; van Dongen, EPA; van Schip, AM, 2020) |
| "Based on the study, we propose specific mg/kg dose reductions with decreasing CKD-EPI values for the obese population, and extension of the dosing interval beyond 24 h when CKD-EPI drops below 50 mL/min/1." | 1.56 | Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function. ( Becker, ML; Brüggemann, RJM; Knibbe, CAJ; Smit, C; van Dongen, EPA; van Schip, AM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smit, C | 1 |
| van Schip, AM | 1 |
| van Dongen, EPA | 1 |
| Brüggemann, RJM | 1 |
| Becker, ML | 1 |
| Knibbe, CAJ | 1 |
| Speybrouck, S | 1 |
| Aelvoet, C | 1 |
| Tollens, T | 1 |
| Vanrykel, JP | 1 |
2 other studies available for gentamicin and Obesity, Morbid
| Article | Year |
|---|---|
Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function.
Topics: Body Weight; Creatinine; Gentamicins; Glomerular Filtration Rate; Humans; Kidney; Obesity, Morbid; P | 2020 |
Use of gentamicin in the treatment of access-port infections.
Topics: Abdominal Wall; Adult; Anti-Bacterial Agents; Female; Gastroplasty; Gentamicins; Humans; Laparoscopy | 2005 |